Intelligent Bio Solutions Inc (NASDAQ:INBS) currently has a daily average trading volume of 157.20K but it saw 875140 shares traded in last market. With a market cap of 11.97M USD, the company’s current market price of $2.49 came rising about 19.71 while comparing to the previous closing price of $2.08. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.09 and as low as $1.00. In the recent trading on the day, stock has struck highest price mark of $2.04 while lowest mark touched by it was $2.54.
Taking a look at 20-day trading activity of Intelligent Bio Solutions Inc (INBS) gives us an average price of $1.67, while its current price level is -64.88% below from 52-week high level whereas it is 149.00% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.55 while that of 200 days or SMA-200 reads an average of $1.71. A closer look into the stock’s movement over the week reveals that its volatility is standing at 15.77% during that period while stretching the period over a month that decreases to 9.39%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 84.08 which implies that the stock is in overbought territory.
Over the week, INBS’s stock price is moving 46.47% up while it is 88.64% when we observe its performance for the past one month. Year-to-date it is 77.86% up and over the past year, the stock is showing a downside performance of -63.19%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Intelligent Bio Solutions Inc’s total number of outstanding shares is 4.81M with 3.02% of that held by the insiders while 14.38% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -169.86% and return on equity (ROE) at -279.27%. Stock’s beta reads 4.71. Stock has a price to book (P/B) ratio of 1.79 while price to sale or P/S ratio amounts to 3.75. Its return on asset (ROA) is -102.00% on average.
